Analyst rating accuracy & track record
Aydin Huseynov is an equity research analyst at Ladenburg Thalmann. Bullish Whales has scored 22 of their stock calls across 15 companies. Their picks beat their sector 35% of the time over the next 12 months, and their price targets were reached 28% of the time within a year.
Track record
Bullish Whales has scored 22 of Aydin Huseynov's stock calls across 15 companies, dating back to 2022. Their rated stocks beat their own sector 35% of the time over the next 12 months. On a typical call, a Huseynov pick returned −24.2% more than its sector over the following year.
Of the scored calls, 22 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.
Coverage & ratings
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 ARDXArdelyx Inc | Buy | $11.00 | Mar 2025 | +11.4% | Miss |
 URGNUroGen Pharma Ltd | Buy | $31.00 | Feb 2025 | +94.8% | Miss |
 MRKRMarker Therapeutics Inc | Buy | $19.00 | Oct 2024 | −74.9% | Miss |
 CRVSCorvus Pharmaceuticals Inc | Buy | $21.00 | Sep 2024 | +14.9% | Miss |
 ACRVAcrivon Therapeutics, Inc. Common Stock | Buy | $16.00 | Sep 2024 | −69.1% | Miss |
 CLDICalidi Biotherapeutics Inc. | Buy | $1.00 | Jun 2024 | −103.2% | Hit |
| MRKRMarker Therapeutics Inc | Buy | $11.00 | Apr 2024 | −72.6% | Miss |
 RNTXRein Therapeutics Inc | Buy | $19.00 | Apr 2024 | −59.4% | Miss |
| ACRVAcrivon Therapeutics, Inc. Common Stock | Buy | $14.00 | Apr 2024 | −72.2% | Miss |
 BDRXBiodexa Pharmaceticals | Buy | $8.00 | Feb 2024 | −90.9% | Miss |
 PMVPPmv Pharmaceuticals Inc | Buy | $7.00 | Dec 2023 | −56.5% | Miss |
| RNTXRein Therapeutics Inc | Buy | $9.00 | Dec 2023 | +4.6% | Miss |
 ATHEAlterity Therapeutics Ltd | Buy | $10.00 | Jun 2023 | −45.8% | Miss |
| CRVSCorvus Pharmaceuticals Inc | Buy | $10.00 | May 2023 | −43.5% | Miss |
 PALIPalisade Bio Inc | Buy | $16.00 | May 2023 | −87.0% | Miss |
 TPSTTempest Therapeutics Inc | Buy | $14.00 | Apr 2023 | +50.0% | Miss |
| CRVSCorvus Pharmaceuticals Inc | Buy | $2.00 | Oct 2022 | +49.6% | Hit |
| TPSTTempest Therapeutics Inc | Buy | $8.00 | Sep 2022 | −84.1% | Miss |
| ATHEAlterity Therapeutics Ltd | Buy | $2.00 | Aug 2022 | −60.1% | Miss |
 ANEBAnebulo Pharmaceuticals Inc | Buy | $6.00 | Jul 2022 | −26.3% | Miss |
 NVCTNuvectis Pharma Inc | Buy | $21.00 | Jul 2022 | +28.3% | Miss |
 QNRXQuoin Pharmaceuticals Ltd DRC | Buy | $2.00 | May 2022 | −100.2% | Hit |
Aydin Huseynov: analyst track record FAQ
Is Aydin Huseynov a good stock analyst?
Yes, by track record. Aydin Huseynov ranks number 308 of 347 of the analysts Bullish Whales scores, with a BW Score of 0 out of 100. Past results do not guarantee future ones.
What is Aydin Huseynov's win rate?
Aydin Huseynov's win rate is 35%. Across 22 scored calls, their rated stocks beat their sector 35% of the time over the next 12 months. On a typical call they returned −24.2% more than the sector.
What stocks and sectors does Aydin Huseynov cover?
Aydin Huseynov covers 15 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.
Are Aydin Huseynov's price targets accurate?
Aydin Huseynov's price targets are reached within 12 months 28% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.
How accurate are Wall Street analyst price targets?
Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.
Should I follow Aydin Huseynov's stock ratings?
Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.
How does Bullish Whales score analyst accuracy?
Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.
How does Aydin Huseynov rank among Wall Street analysts?
Aydin Huseynov ranks number 308 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.